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Abstract
This study aimed to characterize the redox interaction
between 3,4-dihydroxyphenylacetic acid (DOPAC) and nitric
oxide (ÆNO), and to assess the reductive and oxidative decay
pathways of the DOPAC semiquinone originating from this
interaction. The reaction between DOPAC and ÆNO led to the
formation of the DOPAC semiquinone radical, detected by
electron paramagnetic resonance (EPR) and stabilized by
Mg2+, and the nitrosyl anion detected as nitrosylmyoglobin.
The EPR signal corresponding to the DOPAC semiquinone
was modulated as follows: (i) it was suppressed by glutathione
and ascorbic acid with the formation of new EPR spectra
corresponding to the glutathionyl and ascorbyl radical,
respectively; (ii) it was enhanced by Cu,Zn-superoxide
dismutase; the enzyme also accelerated the decay of the
semiquinone species to DOPAC quinone. These results are
interpreted as a one-electron oxidation of DOPAC by ÆNO; the
reductive decay of the semiquinone back to DOPAC was
facilitated by reducing agents, such as glutathione and
ascorbate, whereas the oxidative decay to DOPAC quinone
was facilitated by superoxide dismutase. The latter effect is
understood in terms of a reversible conversion of nitrosyl
anion to ÆNO by the enzyme. The biological relevance of these
reactions is also discussed in terms of the reactivity of
peroxynitrite towards DOPAC as a model with implications for
aerobic conditions.
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Nitric oxide (ÆNO) is a diffusible free radical and membrane
permeant neurotransmitter in brain (Moncada et al. 1991;
Dawson and Dawson 1998). Physiologically ÆNO is
produced by a constitutive neuronal ÆNO synthase (nNOS)
following glutamate stimulation of NMDA receptors and
the subsequent cellular influx of calcium. Excessive stimu-
lation of NMDA receptors may increase ÆNO concentration
in brain, but expression of an inducible, Ca2+-independent
NOS isoform (iNOS) may also occur with the consequent
increase in ÆNO concentration (Dawson and Dawson 1998).
ÆNO reacts at near diffusion-limited rates with other free
radicals and with transition metals in proteins such as
guanylate cyclase and haemoglobin, but despite its free
radical character ÆNO is remarkably unreactive with most
biological molecules at the low concentrations produced
in vivo (Beckman 1996). However, excessive production of
ÆNO is neurotoxic and has been implicated in a variety of
neurological disorders (Dawson and Dawson 1998), inclu-
ding Parkinson’s disease, which is characterized by the loss
of dopaminergic neurones in the nigrostriatal system.
Two salient features of Parkinson’s disease may be
relevant to the context of this study. First, the toxic effects
of ÆNO in Parkinson’s disease are highlighted by recent
findings showing that induction of iNOS in glial cells
contributes to degeneration of dopamine-containing neurones
in a mice model of Parkinson’s disease (Liberatore et al.
1999), and that inhibition of nNOS prevents Parkinsonism in
animal models (Hantraye et al. 1996; Przedborski et al.
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1996; Dehmer et al. 2000; Klivenyi et al. 2000). Second, in
Parkinson’s disease, the metabolism of dopamine is a well
known source of oxidative stress leading to cell death;
dopamine-induced neurotoxicity has been attributed to the
generation of toxic quinones and semiquinones (Graham
et al. 1978; Hastings et al. 1996), autoxidation with produc-
tion of superoxide anion and hydrogen peroxide (Hoyt et al.
1997), consumption of antioxidants (Cohen et al. 1997), and
inhibition of the mitochondrial respiratory chain (Ben-
Shachar et al. 1995). It was also observed that dopamine
causes apoptotic death in neurones by an early insult to
mitochondria affecting components of the respiratory chain
(Wallace et al. 1997; Berman and Hastings 1999). In brain,
3,4-dihydroxyphenylacetic acid (DOPAC) is a major meta-
bolite of dopamine (Kopin 1985) resulting from two
oxidative steps catalysed by monoamine oxidase and alde-
hyde dehydrogenase activities, both located at the mito-
chondrial level (Tank et al. 1981; Ambroziak and Pietruszko
1991; Keung and Vallee 1998).
This study aimed to characterize the redox interaction
between ÆNO and DOPAC, and to assess the reductive and
oxidative decay pathways of the DOPAC semiquinone
radical, an intermediate originating from the aforementioned
interaction, and evaluating the reactivity of peroxynitrite
towards DOPAC, a model with implications for aerobic
experimental conditions.
Materials and methods
Chemicals and biochemicals
DOPAC, glutathione (GSH), ascorbic acid, and Cu,Zn-superoxide
dismutase were purchased from Sigma Chemical Co. (St Louis, MO,
USA). ÆNO gas (Praxair, Danbury, CT, USA) was passed through 5 M
NaOH (two passages) to remove contaminating nitrogen oxides in an
apparatus using only stainless steel or glass tubing. Nitric oxide-
saturated solutions were prepared by flowing ÆNO gas (treated as
described above) through deoxygenated ultra pure water (obtained
from a Milli-Q system; Millipore Company, Bedford, MA, USA) for
30 min. Peroxynitrite was synthesized from sodium nitrite and
hydrogen peroxide according to the procedure described by
Beckman et al. (1994). All other chemicals were of analytical grade.
Nitric oxide measurements
The reaction between ÆNO gas and DOPAC was performed in a
vessel under controlled conditions such that head space was always
1/10th of total volume (to minimize and reproduce ÆNO partition into
the vessel atmosphere). This enabled us to perform reproducible
experiments. Using gas-tight syringes, several volumes of ÆNO gas
were transferred to the reaction mixture, vortexed and the concen-
trations measured electrochemically using the ISO-NOMark II nitric
oxide meter and sensor from WPI (Sarasota, FL, USA). The ÆNO
electrode was calibrated by filling the reaction chamber with KI/
H2SO4 (0.1 M), and titrating with stock solutions of KNO2.
Calibration was also performed using ÆNO-saturated solutions
(prepared as described previously; Koppenol 1998).
Spectroscopic measurements
Electron paramagnetic resonance (EPR) spectra were recorded on
a Brucker ECS 106 spectrometer (Bruker Instruments Inc.,
Billerica, MA, USA) at room temperature (24C) using the
following instrument settings (unless otherwise stated): microwave
frequency, 9.8 GHz; microwave power, 20 mW; sweep width,
30 G; modulation amplitude, 0.96 G; time constant, 0.65 s; sweep
rate, 20 G/min. Reaction mixtures challenged with ÆNO gas
(treated as described above) or with ÆNO-saturated solutions were
immediately transferred (avoiding contamination with oxygen)
to bottom-sealed Pasteur pipettes and the EPR spectra were
recorded.
o-Semiquinone radicals were measured under conditions of spin-
stabilization with 0.2 M Mg2+. This approach, which significantly
enhances radical concentration allowing the unambiguous identifi-
cation of semiquinone species, has been widely applied to the study
of catecholamine-derived radicals (Kalyanaraman et al. 1984;
Kalyanaraman et al. 1987).
Absorption spectra were recorded on a Hitachi U3110 absorp-
tion spectrophotometer (Hitachi Instruments Inc., San Jose, CA,
USA). Spectra of metmyoglobin were recorded in the 450–
680 nm range. Metmyoglobin concentration was calculated from
e630 ¼ 3.42 mM)1 cm)1 and nitrosylmyoglobin from e575 ¼
10.5 M)1 cm)1 (Antonini and Brunori 1971). DOPAC quinone
formation was followed at 415 nm.
Results
Oxidation of DOPAC by ÆNO
The semiquinone form of DOPAC, stabilized by Mg2+,
was detected by EPR upon incubation of DOPAC with
ÆNO under anaerobic conditions. The EPR signal intensity
increased linearly with increasing ÆNO concentrations
(Fig. 1) and decreased with time. In the presence of O2,
the semiquinone radical of DOPAC is also observed, but
linearity between radical intensity and ÆNO concentration
is lost, suggesting that competing reactions are occurring
(not shown). Under anaerobic conditions, and at variance
with DOPAC, dopamine semiquinone radical was not
detected upon incubation of dopamine with ÆNO (not
shown). The formation of the DOPAC semiquinone
suggests a one-electron oxidation of DOPAC by ÆNO
(reaction 1):
ð1Þ
with concomitant reduction of ÆNO to nitrosyl anion (NO–).
The formation of the latter was confirmed by detection of
nitrosylmyoglobin (reaction 2; k2 ¼ 6.4 · 105 M)1 s)1)
(Goretski and Hollocher 1988):
Mb½FeIII þ NO ! Mb½FeIII  NO ð2Þ
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incubation of metmyoglobin with DOPAC/ÆNO resulted in a
decrease in the 503 and 630 nm absorption of metmyoglobin,
and an increase at 542 and 580 nm; isosbestic points were at
602, 531 and 481 nm. The absorption at 578–580 nm is
characteristic of nitrosylmyoglobin (Antonini and Brunori
1971): under the experimental conditions of Fig. 2, approxi-
mately 90% of ÆNO was recovered in the form of nitrosyl-
myoglobin.
Oxidation of DOPAC by peroxynitrite
DOPAC semiquinone radical is rapidly formed upon incu-
bation of DOPAC with peroxynitrite (ONOO–), the product
of the reaction between O2
–Æ and ÆNO (reaction 3; k3 ¼
1.9 · 1010 M)1 s)1; Huie and Padmaja 1993):
O	2 þ 	NO! ONOO ð3Þ
The EPR spectrum shown in Fig. 3 supports the notion of
oxidation of DOPAC by an oxidant contained in the cage
formed by ONOO– protonation to peroxynitrous acid
(reaction 4) in a manner similar to that described for the
oxidation of ubiquinol by peroxynitrite (Schopfer et al.
2000)
ONOO þ Hþ ! ONOOH, HO	 . . . . . .NO	2: ð4Þ
It is likely that DOPAC semiquinone formation follows the
mechanism outlined in reaction 5:
ð5Þ
This does not rule out a second oxidation by nitrogen dioxide
(NO2Æ) (reaction 6), a potent oxidant (E
0,
NO2
Æ/NO2
– ¼ 1.0 V)
also expected to be formed during the trimolecular reaction
of ÆNO with O2 (a mechanism viable in aerobic conditions)
(reaction 7):
ð6Þ
2	NOþ O2 !! 2NO	2 ð7Þ
Upon incubation of dopamine with peroxynitrite, an EPR
signal, ascribed to the semiquinone obtained after the first
one-electron oxidation of dopamine, was also observed
(Fig. 3b).
Fig. 1 Oxidation of DOPAC by nitric oxide: EPR spectra of DOPAC
semiquinone. The reaction mixture consisted of 1 mM DOPAC in 0.1 M
Tris/0.1 mM DTPA buffer, pH 7.4 (final volume 1 mL). The reaction
mixture was purged with He. The reaction was initiated by addition of
nitric oxide gas under controlled conditions to yield solutions containing
38 (a), 170 (b) and 335 lM (c) of nitric oxide. Spectra are representative
of several independent experiments. Instrument settings and other
assay conditions as described in the Materials and methods section.
Fig. 2 Detection of nitrosyl anion by nitrosylmyoglobin formation.
Metmyoglobin spectral changes following the addition of DOPAC and
nitric oxide. The reaction mixture consisted of 50 lM metmyoglobin,
1 mM DTPA and 1 mM DOPAC in 50 mM phosphate buffer, pH 7.4,
purged with He. The reaction was initiated by adding nitric oxide gas
(30 lM final concentration). Scans were recorded with 5 min intervals.
Upward and downward arrows indicate increase and decrease of
absorbance, respectively. (a) absorption spectrum of metmyoglobin.
(b) Absorption spectrum of nitrosylmyoglobin. Ascorbate added at the
end of the reaction exerted no spectral modifications.
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Formation of glutathionyl and ascorbyl radicals
during the oxidation of DOPAC by ÆNO
The EPR signal ascribed to DOPAC semiquinone (Fig. 4a)
and formed during the oxidation of DOPAC by ÆNO in
anaerobiosis was abolished by GSH: spin trapping EPR
showed a new signal ascribed to the adduct of thiyl radical of
GSH (glutathionyl radical) with DMPO (aN ¼ 15.4 G;
aH ¼ 16.2 G; Fig. 4b). Likewise, the EPR signal of
the DOPAC semiquinone was abolished by ascorbate and a
new signal corresponding to the characteristic doublet of
ascorbyl radical (aH ¼ 1.8 G) was observed (Fig. 4c).
These findings suggest that DOPAC semiquinone oxidizes
glutathione and ascorbate with formation of glutathionyl and
ascorbyl radicals, respectively (reaction 8).
ð8Þ
Note that these experiments were carried out in anaero-
biosis; hence, the redox transition DOPAC semiqui-
none fi DOPAC (reductive decay) is expected to be
facilitated by glutathione and ascorbate, and rules out the
involvement of oxyradicals derived from DOPAC semi-
quinone autoxidation in the formation of glutahionyl and
ascorbyl radicals.
Effect of superoxide dismutase on DOPAC oxidation
by ÆNO
In anaerobic conditions, Cu,Zn-superoxide dismutase elicited
the following effects on the oxidation of DOPAC by ÆNO.
Superoxide dismutase increased the EPR signal intensity
of DOPAC semiquinone arising from the oxidation
of DOPAC by ÆNO
Figure 5 shows the decay of DOPAC semiquinone radical
with time in the absence (Fig. 5a) and the presence of
superoxide dismutase (Fig. 5b). The magnitude of the
increase was dependent on superoxide dismutase concentra-
tion. Superoxide dismutase had no effect on DOPAC in the
absence of ÆNO. The effect of different concentrations of
superoxide dismutase on the decay of the DOPAC semi-
quinone EPR signal is shown in Fig. 6.
The enhancement of the EPR signal decay intensity by
superoxide dismutase, and its faster decay in the presence of
the enzyme, may be understood in terms of the removal of
the nitrosyl anion product (reaction 1) by Cu2+-superoxide
Fig. 4 Formation of glutathionyl and ascorbyl radicals during the
interaction of DOPAC with ÆNO. (a) EPR spectrum of DOPAC semi-
quinone. Assay conditions as in Fig. 1. (b) EPR spectrum of the
glutathionyl radical-DMPO adduct. The reaction mixture consisted of
1 mM DOPAC, 50 lL nitric oxide gas, 200 mM DMPO in 110 mM NaCl/
20 mM phosphate buffer, pH 7.4. 1 mM GSH was added to the buffer
after DOPAC and nitric oxide. Sweep width: 80 G. (c) Spectrum of
ascorbyl radical. Assay conditions as in (b) but sweep width 30 G and
1 mM ascorbate instead of GSH in the absence of the spin trap,
DMPO. Also, spectrum (a) is represented in a different scale intensity
relatively to (b) and (c).
Fig. 3 Oxidation of DOPAC and dopamine by peroxynitrite: EPR
spectra of DOPAC and dopamine semiquinones. The reaction mixture
consisted of 1 mM DOPAC (a) or 1 mM dopamine (b) in 0.1 M Tris/
0.1 mM DTPA buffer, pH 7.4 (final volume 1 mL). The reaction was
initiated by a bolus addition of 400 lM peroxynitrite. Instrument set-
tings and other conditions as described in the Materials and methods
section. Spectra (a) and (b) are represented under different intensity
scales.
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dismutase (reaction 9). This leads to two effects: first, it
enhances the oxidation of DOPAC by ÆNO, thereby increas-
ing the signal intensity, and second, it accelerates the
decay of the DOPAC semiquinone. The kinetic control of
ÆNO-mediated DOPAC oxidation by superoxide dismutase
appears to be accomplished within a cycle involving
the ÆNO fi NO– transition during DOPAC oxidation
(reaction 1) and the NO– fi ÆNO transition coupled to the
reduction of Cu2+ in superoxide dismutase (reaction 9),
displacing reaction 1 to the right:
SODCu2þ þ NO ! SODCuþ þ 	NO ð9Þ
The redox role of copper in superoxide dismutase in the
enhancement of the DOPAC semiquinone EPR signal was
substantiated by two approaches: first, cyanide inhibited the
enhancing effect elicited by superoxide dismutase (Fig. 7c),
and second, the effect of superoxide dismutase was mim-
icked by copper (Fig. 7d); as expected, the copper-enhance-
ment of the DOPAC semiquinone signal was not sensitive to
cyanide (Fig. 7e). Of note, copper (sulphate) used here is not
a catalytic model for the general activity of SOD but a model
for the activity of copper in SOD on the decay of the DOPAC
radical.
Superoxide dismutase competed with myoglobin for NO–
Figure 8 shows the absorption spectral changes occurring
during the oxidation of DOPAC by ÆNO and the ensuing
nitrosylmyoglobin formation. A 50% inhibition of
nitrosylmyoglobin formation was observed in the presence
of superoxide dismutase. The effects of two superoxide
dismutase concentrations on the time course of nitrosyl-
myoglobin formation are shown in Fig. 8(c). This inhib-
itory effect on nitrosylmyoglobin formation is a
Fig. 5 Effect of superoxide dismutase on DOPAC semiquinone
formation. The reaction mixture consisted of 1 mM DOPAC in 0.1 M
Tris/0.1 mM DTPA buffer, pH 7.4. The reaction was initiated by addi-
tion of 10 lL nitric oxide gas. (a) Control. Spectra of DOPAC radical
taken at (i) 0, (ii) 3, (iii) 6, (iv) 9, and (v) 15 min. (b) As in (a) but in the
presence of 12.5 lM Cu,Zn-superoxide dismutase. Instrument settings
and other conditions are described in the Materials and methods
section.
Fig. 6 Effect of superoxide dismutase on DOPAC semiquinone signal
intensity and decay. (a) Time course of DOPAC semiquinone decay in
the absence (i) and presence (ii) of 25 lM superoxide dismutase.
Assay conditions as in Fig. 4. (b) Dependence of signal intensity and
t1/2 on superoxide dismutase concentration.
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consequence of the competition between metmyoglobin
(reaction 2) and superoxide dismutase (reaction 9) for
NO–.
Superoxide dismutase enhanced the formation
of DOPAC quinone
Accumulation of DOPAC quinone in the presence of
superoxide dismutase occurred at initial rates 2.5-fold
faster than in its absence (Fig. 9). The formation of
DOPAC quinone (in the absence and presence of superoxide
dismutase) in anaerobic conditions is expected to occur by
disproportionation (reaction 10):
ð10Þ
Discussion and conclusions
This study – carried out under anaerobic conditions –
provides evidence for the oxidation of DOPAC by ÆNO and
the modulation of this redox reaction by glutathione,
ascorbate and Cu,Zn-superoxide dismutase.
Formation of DOPAC semiquinone
The primary reaction proceeds with production of DOPAC
semiquinone and NO–, their occurrence confirmed by EPR
and absorption (nitrosylmyoglobin formation) spectroscopy,
respectively (reactions 1 and 2). The formation of nitrosyl-
myoglobin cannot provide an indirect measure of the rate of
DOPAC oxidation by ÆNO, for it may impose a kinetic control
on the primary reaction: although nitrosylmyoglobin forma-
tion proceeds at modest rates (k2 ¼ 6.4 · 105 M)1 s)1), the
removal of NO– by the haemoprotein may accelerate DOPAC
oxidation. It is also expected that the monoanionic form of
DOPAC (reaction 1) is participating in the electron transfer
reaction with ÆNO, for deprotonation is a requisite condition
for electron transfer. DOPAC quinone formation may be
expected to originate from disproportionation (reaction 10) as
shown in pulse radiolysis studies for the case of melanine
precursor, 3,4-dihydroxyphenylalanine (Chedekel et al.
1984; Thompson et al. 1985).
Reductive decay of DOPAC semiquinone
Based on the suppression of the DOPAC semiquinone signal
and the appearance of a glutathionyl or ascorbyl radical signal
in reaction mixtures containing glutathione and ascorbate,
respectively, it may be surmised that these electron donors
favoured the reduction of DOPAC semiquinone back to
DOPAC (reaction 8). The reduction of DOPAC semiquinone
by ascorbate is thermodynamically feasible [E(AÆ–/A–) ¼
0.282 mV] (Koppenol and Butler 1985), whereas that by
glutathione [E(GSÆ/GS–) ¼ 0.85–1.3 V] (Surdhar and Arm-
strong 1986) may be driven by either the decay pathways of
the glutathionyl radical (e.g. its conjugation with thiolate:
GSÆ + GS– fi GSSG–Æ) or – as in the conditions of
Fig. 4 – its reaction with the spin trap (kDMPO + GSÆ ¼
107)108 M)1 s)1) (Davies et al. 1987).
Acceleration of DOPAC semiquinone formation
and oxidative decay
Superoxide dismutase accelerates DOPAC semiquinone
formation as well as the decay of the semiquinone species:
this effect may be interpreted on the basis of a redox cycle
involving the reversible conversion of nitrosyl anion to ÆNO
by superoxide dismutase (Murphy and Sies 1991); ÆNO thus
formed, would potentiate DOPAC semiquinone formation
and its faster decay. In the experimental conditions in this
study – assays carried out in anaerobic conditions – the
accumulation of DOPAC quinone (Fig. 9) by autoxidation
may be ruled out, whereas disproportionation appears to be
the major mechanism underlying the formation of the
quinone (Thompson et al. 1985).
The effect of superoxide dismutase on the fate of DOPAC
semiquinone and the primary reaction between DOPAC and
Fig. 7 Modulation of DOPAC semiquinone signal intensity: role of
copper. The reaction mixture consisted of 1 mM DOPAC in 0.1 M Tris,
pH 7.4. The reaction mixture was purged with He. The reaction was
initiated by the addition of 10 lL nitric oxide gas. (a) No further addi-
tions. (b) Plus 12 lM superoxide dismutase. (c) Plus 12 lM superoxide
dismutase and 100 lM cyanide. (d) Plus 12 lM CuSO4. (e) Plus 12 lM
CuSO4 and 100 lM cyanide.
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ÆNO needs further analysis within the frame of its physio-
logical implications: the effect of superoxide dismutase
described here in connection with DOPAC metabolism is
expected to shift the redox status of the cell towards a more
oxidized state. This notion may be strengthened by the
augmentation of DOPAC quinone levels, the reutilization of
ÆNO within a reductive pathway (see above and reaction 1)
associated with an increase in DOPAC quinone levels, and
channeling of the Cu+/Cu2+ cycles in superoxide dismutase
to nitrogen metabolism rather than OÆ–2 reduction. Of course,
these notions depend on the steady state levels of the
individual reactants and the rate constants of the reactions
involved.
Biological significance
The implications of this study for biological systems gain
significance in view of the following.
(i) Glutamate potentiates simultaneously ÆNO production
and the toxic effects of dopamine towards neuronal cells
(Garthwaite and Boulton 1995).
(ii) ÆNO regulates dopamine release in the hippocampus of
rats (Segieth et al. 2000; Wegener et al. 2000) through
activation of the guanylate cyclase pathway (Peterson et al.
1995), and also affects dopamine reuptake (Cook et al. 1996).
(iii) ÆNO activates tyrosine hydroxylase (the rate-limiting
enzyme in the synthesis of dopamine) in PC12 cells
(Roskoski and Roskoski 1987).
(iv) The activity of the recently described nitric oxide
synthase in mitochondria (mtNOS) (Ghafourifar and Richter
1997; Giulivi et al. 1998) provides a site-specific setting for
the oxidation of DOPAC by ÆNO: first, the steady-state level
of ÆNO in the mitochondrial matrix is expected to be high,
partially as a result of the activity of mtNOS (3 · 10)8 M;
Boveris et al. 2000); second, and at least temporarily,
DOPAC synthesis is expected to occur in the mitochondrial
matrix via the activity of the rather unspecific aldehyde
dehydrogenase (Tank et al. 1981; Ambroziak and Pie-
truszko 1991; Keung and Vallee 1998); third, the produc-
tion of OÆ–2, by the mitochondrial respiratory chain
[enhanced by ÆNO inhibition of the bc1 segment (Poderoso
et al. 1996) in an antimycin-like fashion] contribute to
peroxynitrite formation via the diffusion-controlled rate of
the reaction between ÆNO and O2
–Æ. Given this scenario, the
oxidation of DOPAC by ONOO– (Fig. 3) may be an
important source of DOPAC semiquinone and ensuing
redox transitions of this species. Therefore, it may be
surmised that, in perfect aerobic conditions, NO would
oxidize DOPAC to o-semiquinone indirectly through per-
oxynitrite formation.
Thus, either dopamine or its metabolites may be potential
targets for ÆNO and derived oxidants, affecting the physio-
Fig. 8 Effect of superoxide dismutase on nitrosylmyoglobin formation.
(a) Assay conditions: 0.5 mM DOPAC, 5 lM metmyoglobin, 1 mM
DTPA in 50 mM potassium phosphate buffer, pH 7.4, and supple-
mented with 28 lM nitric oxide to initiate the reaction. (b) As in (a) in
the presence of 1.7 lM superoxide dismutase. (c) Time course of
nitrosylmyoglobin formation. Assay conditions as in (a): (i) no further
additions; (ii) plus 4 lM superoxide dismutase; (iii) plus 16.6 lM
superoxide dismutase.
Fig. 9 Time course of DOPAC quinone formation. Assay conditions:
2 mM DOPAC and 0.2 M Mg2+ in He-purged 0.1 M Tris buffer, pH 7.4;
the reaction was started with the addition of 28 lM nitric oxide (arrow).
(a) control; (b) plus 4 lM superoxide dismutase. Other assay condi-
tions as in the Materials and methods section.
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logical chemistry of both ÆNO and catecholamines. In line
with this hypothesis, it has been shown that ÆNO promoted
nitration of dopamine in aerobic solutions, and that the
nitrated dopamine failed to increase 2¢,5¢-cyclic adenosine
monophosphate (cAMP) formation in cultured striatal neu-
rones (Daveu et al. 1997). The modulation of the DOPAC/
ÆNO interaction by ascorbate and glutathione gains further
significance when considering that these antioxidants are
present in the mM range in the brain. Concerning the effects
elicited by superoxide dismutase, it may be noted that its
activity is increased in substantia nigra in Parkinson’s
disease (Saggu et al. 1989).
Acknowledgements
JL acknowledges support from Fundac¸a˜o Luso-Americana (grant
419/97). Supported by grant PRAXIS/P/BIA/1395/1998. Work
supported by grant AG16718 from the National Institutes of Health,
Bethesda, MD, USA.
References
Ambroziak W. and Pietruszko R. (1991) Human aldehyde dehydro-
genase. Activity with aldehyde metabolites of monoamines,
diamines, and polyamines. J. Biol. Chem. 266, 13011–13018.
Antonini E. and Brunori M. (1971) Hemoglobin and Myoglobin in Their
Reactions with Ligands, pp. 219–234. North Holland, Amsterdam.
Beckman J. S. (1996) The physiological and pathological chemistry of
nitric oxide, in Nitric Oxide: Principles and Actions (Lancaster, J.,
ed.), pp. 1–82. Academic Press, San Diego.
Beckman J. S., Chen J., Ischiropoulos H. and Crow J. P. (1994)
Oxidative chemistry of peroxynitrite. Meth Enzymol. 233,
229–240.
Ben-Shachar D., Zuk R. and Glinka Y. (1995) Dopamine neurotoxicity:
inhibition of mitochondrial respiration. J. Neurochem. 64, 718–723.
Berman S. B. and Hastings T. G. (1999) Dopamine oxidation alters
mitochondrial respiration and induces permeability transition
in brain mitochondria: implications for Parkinson’s disease.
J. Neurochem. 73, 1127–1137.
Boveris A., Costa L. E., Poderoso J. J., Carreras M. C. and Cadenas E.
(2000) Regulation of mitochondrial respiration by oxygen and
nitric oxide. Ann. NY Acad. Sci. 899, 121–135.
Chedekel M. R., Land E. J., Thompson A. and Truscott T. G. (1984)
Early steps in the free radical polymerisation of 3,4-dihydro-
xyphenylalanine (Dopa) into melanine. J. Chem. Soc. Chem.
Commun. 17, 1170–1172.
Cohen G., Farooqui R. and Kesler N. (1997) Parkinson disease: a new
link between monoamine oxidase and mitochondrial electron flow.
Proc. Natl Acad. Sci. USA 94, 4890–4894.
Cook J. A., Wink D. A., Blount V., Krishna M. C. and Hanbauer I.
(1996) Role of antioxidants in the nitric oxide-elicited inhibition of
dopamine uptake in cultured mesencephalic neurons. Insights into
potential of nitric oxide-mediated neurotoxicity. Neurochem. Int.
28, 609–617.
Daveu C., Servy C., Dendane M., Marin P. and Ducrocq C. (1997)
Oxidation and nitration of catecholamines by nitrogen oxides
derived from nitric oxide. Nitric Oxide 1, 234–243.
Davies M. J., Forni L. G. and Shuter S. L. (1987) Electron spin reson-
ance and pulse radiolysis studies on the spin trapping of sulphur-
centered radicals. Chem. Biol. Interact. 61, 177–188.
Dawson V. L. and Dawson T. M. (1998) Nitric oxide in neurodegener-
ation. Prog. Brain Res. 118, 215–229.
Dehmer T., Lindenau J., Haid S., Dichgans J. and Schulz J. B. (2000)
Deficiency of inducible nitric oxide synthase protects against
MPTP toxicity in vivo. J. Neurochem. 74, 2213–2216.
Garthwaite J. and Boulton C. L. (1995) Nitric oxide signaling in the
central nervous system. Ann. Rev. Physiol. 57, 683–706.
Ghafourifar P. and Richter C. (1997) Nitric oxide synthase activity in
mitochondria. FEBS Lett. 418, 291–296.
Giulivi C., Poderoso J. J. and Boveris A. (1998) Production of nitric
oxide by mitochondria. J. Biol. Chem. 273, 11038–11043.
Goretski J. and Hollocher T. C. (1988) Trapping of nitric oxide produced
during denitrification by extracellular hemoglobin. J. Biol. Chem.
263, 2316–2323.
Graham D. G., Sylvia M. T., Bell W. R. and Gutknecht W. F. (1978)
Autoxidation versus covalent binding of quinones as the mechan-
ism of toxicity of dopamine, 6-hydroxydopamine, and related
compounds toward C1300 neuroblastoma cells in vitro. Mol.
Pharmacol. 14, 644.653.
Hantraye P., Brouillet E., Ferrante R., Palfi S., Dolan R., Matthews R. T.
and Beal M. F. (1996) Inhibition of neuronal nitric oxide synthase
prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2,
1017–1021.
Hastings T. G., Lewis D. A. and Zigmond M. J. (1996) Role of oxidation
in the neurotoxic effects of intrastriatal dopamine injections. Proc.
Natl Acad. Sci. USA 93, 1956–1961.
Hoyt K. R., Reynolds I. J. and Hastings T. G. (1997) Mechanisms of
dopamine-induced cell death in cultured rat forebrain neurons:
interactions with and differences from glutamate-induced cell
death. Exp. Neurol. 143, 269–281.
Huie R. E. and Padmaja S. (1993) The reaction rate of nitric oxide with
superoxide. Free Rad. Res. Commun. 18, 195–199.
Kalyanaraman B., Felix C. C. and Sealy R. C. (1984) Electron spin
resonance-spin stabilization semiquinones produced during oxida-
tion of epinephrine and its analogues. J. Biol. Chem. 259, 354–358.
Kalyanaraman B., Premovic P. I. and Sealy R. C. (1987) Semiquinone
anion radicals from addition of amino acids, peptides, and proteins to
quinones derived from oxidation of catechols and catecholamines.
An ESR spin stabilization study. J. Biol. Chem. 262, 11080–11087.
Keung W. M. and Vallee B. L. (1998) Daidzin and its antidipsotropic
analogs inhibit serotonin and dopamine metabolism in isolated
mitochondria. Proc. Natl Acad. Sci. USA 95, 2198–2203.
Klivenyi P., Andreassen O. A., Ferrante R. J., Lancelot E., Reif D. and
Beal M. F. (2000) Inhibition of neuronal nitric oxide synthase
protects against MPTP toxicity. Neuroreport. 11, 1265–1268.
Kopin I. J. (1985) Catecholamine metabolism: basic aspects and clinical
significance. Pharmacol. Rev. 37, 333–364.
Koppenol W. H. (1998) The basic chemistry of nitrogen monoxide and
peroxynitrile. Free Radic. Biol. Med. 25, 385–391.
Koppenol W. H. and Butler J. (1985) Energetics of interconversion of
oxyradicals. Adv. Free Rad. Biol. Med. 1, 91–131.
Liberatore G. T., Jackson-Lewis V., Vukosavic S., Mandir A. S., Vila M.,
McAuliffe W. G., Dawson V. L., Dawson T. M. and Przedborski S.
(1999) Inducible nitric oxide synthase stimulates dopaminergic
neurodegeneration in the MPTP model of Parkinson disease. Nat.
Med. 5, 1403–1409.
Moncada S., Palmer R. M. and Higgs E. A. (1991) Nitric oxide: phy-
siology, pathophysiology, and pharmacology. Pharmacol. Rev. 43,
109–142.
Murphy M. E. and Sies H. (1991) reversible conversion of nitroxyl anion
to nitric oxide by superoxide dismutase. Proc. Natl Acad. Sci. USA
88, 10860–11864.
Peterson C. L., Thompson M. A., Martin D. and Nadler J. V. (1995)
Modulation of glutamate and aspartate release from slices of hip-
Oxidation of DOPAC by nitric oxide 899
 2002 International Society for Neurochemistry, Journal of Neurochemistry, 81, 892–900
pocampal area CA1 by inhibitors of arachidonic acid metabolism.
J. Neurochem. 64, 1152–1160.
Poderoso J. J., Carreras M. C., Lisdero C., Riobo N., Schopfer F. and
BoverisA. (1996)Nitric oxide inhibits electron transfer and increases
superoxide radical production in rat heart mitochondria and sub-
mitochondrial particles. Arch. Biochem. Biophys. 328, 85–92.
Przedborski S., Jackson-Lewis V., YokoyamaR., Shibata T., DawsonV. L.
and Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminer-
gic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565–4571.
Roskoski R. Jr and Roskoski L. M. (1987) Activation of tyrosine
hydroxylase in PC12 cells by the cyclic GMP and cyclic AMP
second messenger systems. J. Neurochem. 48, 236–242.
Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P.
and Marsden C. D. (1989) A selective increase in particulate
superoxide dismutase activity in parkinsonian substantia nigra.
J. Neurochem. 53, 692–697.
Schopfer F., Riobo N., Carreras M. C., Alvarez B., Radi R., Boveris A.,
Cadenas E. and Poderoso J. J. (2000) Oxidation of ubiquinol by
peroxynitrite: implications for protection of mitochondria against
nitrosative damage. Biochem. J. 349, 35–42.
Segieth J., Fowler L., Whitton P. and Pearce B. (2000) Nitric oxide-
mediated regulation of dopamine release in the hippocampus
in vivo. Neuropharmacology 39, 571–577.
Surdhar P. S. and Armstrong D. A., (1986) Redox potentials of some
sulfur-containing radicals. J. Phys. Chem. 90, 5915–5917.
Tank A. W., Weiner H. and Thurman J. A. (1981) Enzymology and sub-
cellular localization of aldehyde oxidation in rat liver. Oxidation of
3,4-dihydroxyphenylacetaldehyde derived fromdopamine to 3,4-
dihydroxyphenylacetic acid. Biochem. Pharmacol. 30, 3265–3275.
Thompson A., Land E. J., Chedekel M. R., Subbarao K. V. and Truscott
T. G. (1985) A pulse radiolysis investigation of the oxidation of the
melanin precursors 3,4-dihydroxyphenylalanine (dopa) and the
cysteinyldopas. Biochim. Biophys. Acta 843, 49–57.
Wallace D. C., Lott M. T. and Brown M. D. (1997) Mitochondrial
defects in neurodegenartive diseases and aging, in Mitochondria
and Free Radicals in Neurodegenerative Diseases (Beal M. F.,
Howel N. and Bodis-Wollner I., eds), pp. 277–289. Wiley-Liss,
Inc., New York.
Wegener G., Volke V. and Rosenberg R. (2000) Endogenous nitric oxide
decreases hippocampal levels of serotonin and dopamine in vivo.
Br. J. Pharmacol. 130, 575–580.
 2002 International Society for Neurochemistry, Journal of Neurochemistry, 81, 892–900
900 J. Laranjinha and E. Cadenas
